Study touts benefits of imaging agent regadenoson

12/3/2009 | (free registration)

A study of patients with end-stage renal disease found that regadenoson, a vasodilator stress myocardial perfusion imaging agent, is safe and tolerable and is comparable to adenosine. "Unlike adenosine, it can be safely employed in patients with moderate airway disease or asthma," the lead investigator said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC